Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06676904 · ClinicalTrials.gov registry record · NA
Neonatal Platelet Transfusion Threshold Trial
A NA study of Thrombosis and Thrombocytopenia, sponsored by NICHD Neonatal Research Network.
- Recruiting
- Registry status
- NA
- Development phase
- 2,433
- Enrollment target
- 20
- Study locations
NCT06676904: Recruiting NA study of Thrombosis and Thrombocytopenia, sponsored by NICHD Neonatal Research Network.
NCT06676904 is a NA study of Thrombosis and Thrombocytopenia that is actively recruiting participants, run by NICHD Neonatal Research Network. The registered enrollment target is 2,433 participants, above the 383-participant average among 28 other Thrombosis trials with a reported enrollment target (535% higher). The trial reports 20 study locations across 15 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06676904, a NA study of Thrombosis and Thrombocytopenia, is actively recruiting participants, sponsored by NICHD Neonatal Research Network.
- RECRUITING
- Registry status
- NA
- Development phase
- 2,433 participants
- Enrollment target
- 20
- Study locations
Study Summary
The objective of the NeoPlaTT trial is to test whether, among extremely preterm infants born at 23 0/7 to 26 6/7 weeks' gestation, a lower platelet transfusion threshold, compared to a higher threshold, improves survival without major or severe bleeding up to 40 0/7 weeks' postmenstrual age (PMA).
Primary Outcome
Bleeding will be assessed using the neonatal Bleeding Assessment Tool (NeoBAT), a validated bleeding assessment tool (Venkatesh V, 2013)
Conditions Studied
Interventions
- PROCEDURE Higher Platelet Transfusion Threshold
- PROCEDURE Lower Platelet Transfusion Threshold
Study Locations (20)
Ohio
- Cincinnati Children's Medical Center - Cincinnati
- Case Western Reserve University, Rainbow Babies and Children's Hospital - Cleveland
- Nationwide Children's Hospital - Columbus
Texas
- University of Texas Southwestern Medical Center at Dallas - Dallas
- University of Texas Health Science Center at Houston - Houston
- Pediatrix Medical Group - San Antonio
California
- Stanford University - Palo Alto
- Sharp Mary Birch Hospital for Women & Newborns - San Diego
Alabama
- University of Alabama at Birmingham - Birmingham
Colorado
- University of Colorado - Aurora
Georgia
- Emory University - Atlanta
Illinois
- Northwestern Lurie Children's Hospital of Chicago - Chicago
Iowa
- University of Iowa - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,433 participants |
| Start Date | 2025-06-13 |
| Est. Completion | 2031-04-30 |
| Phase | NA |
What NCT06676904 shows while recruiting
NCT06676904 is an interventional study that assigns participants to a tested intervention. Its 2,433 participants enrollment target places it among the larger protocols in the corpus, above the 383-participant average among 28 other Thrombosis trials with a reported enrollment target (535% higher).
The record links to 7 conditions, with Thrombosis appearing as the primary indexed condition, and to 2 interventions - of which Higher Platelet Transfusion Threshold is the first listed.
NCT06676904 names 20 study sites across 15 states, led by Ohio, Texas, California.
Frequently Asked Questions
What is clinical trial NCT06676904 about?
NCT06676904 is a clinical study titled "Neonatal Platelet Transfusion Threshold Trial". The objective of the NeoPlaTT trial is to test whether, among extremely preterm infants born at 23 0/7 to 26 6/7 weeks' gestation, a lower platelet transfusion threshold, compared to a higher threshold, improves survival without major or severe bleeding up to 40 0/7 weeks' postmenstrual age (PMA).
What is the current status of trial NCT06676904?
This trial is currently recruiting. It is a NA study. The enrollment target is 2,433 participants. The study started on 2025-06-13. Estimated completion is 2031-04-30.
What conditions does trial NCT06676904 study?
This clinical trial studies the following conditions: Thrombosis, Thrombocytopenia, Infant, Small for Gestational Age, Infant, Newborn, Diseases, Neonatal.
What interventions are being tested in trial NCT06676904?
The interventions under investigation include: Higher Platelet Transfusion Threshold (PROCEDURE), Lower Platelet Transfusion Threshold (PROCEDURE).
Who is sponsoring clinical trial NCT06676904?
This trial is sponsored by NICHD Neonatal Research Network, which has 61 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06676904 being conducted?
This trial has 20 study locations across Alabama, California, Colorado, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thrombosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06676904's enrollment target sits among peer trials
2,433 2nd of 28 the highest of 28 other Thrombosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Thrombosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Prophylactic Low-molecular Weight Heparin Dosing on Clotting Parameters Following Cesarean Delivery
COMPLETED · NA
-
PFA-100 Responsive to Effect of Energy Drinks on Platelet Function
COMPLETED · NA
-
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
RECRUITING
-
Positron Emission Tomography (PET) Imaging of Thrombosis
RECRUITING · Phase 1
-
Pharmacogenomics of Warfarin in Hispanics and Latinos
RECRUITING
-
Vascular Lab Resource (VLR) Biorepository
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06128304 · 2,436 participants · NA
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
- NCT05345951 · 2,425 participants · NA
Project e-PBI+ - Parent Intervention to Reduce College Student Drinking and Cannabis Use
- NCT05873387 · 2,420 participants
Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope
- NCT06898593 · 2,448 participants · NA
Enhancing Engagement by Integrating Goals and Concerns That Matter to Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI